Fellows' corner

View all posts »

Episode #10: Biomarkers of heart failure with Jim Januzzi

May 19, 2009 11:00 EDT


Where are the opportunities for cardiology fellows considering research in the field of biomarkers of heart failure? In this interview conducted by Dr Rahul Kakkar, Dr Jim Januzzi gives his insight into research that has applicability spanning the full range of the American Heart Association's stages of heart failure.



« Previous Post
Episode #11: Transradial access for PCI with Drs David Kandzari, Sunil Rao, and Philippe Généreux
Jun 26, 2009 13:15 EDT Next post »
Episode #9: From fellow to independent principal investigator: Insight from Dr Deepak Bhatt
Apr 16, 2009 15:20 EDT



Your comments
Episode #10: Biomarkers of heart failure with Jim Januzzi
# 1 of 4
June 9, 2009 08:44 (EDT)
Sadaboy India

 Hi Good morning!Congratulations for this great attainment.This seems to predict heart attacks well ainadavance so that prophylactic steps can be initiated on a war footing.

Incidentally my US citizen eldest brother died suddenly of heart failure in Michigan last week.

Please let me log in to your radio service. Also to my cardiologist whose id is girija_garnet@yahoo.com.she is a brillaint person.

Dr Sadasivan (id:edelweiss97a@yahoo.in)

# 2 of 4
December 7, 2009 07:55 (EST)
Randox

Randox have just launched new biochip array technology, which gives early diagnosis of myocardial infarction (MI) and ACS.

 The cardiac array combines routine with novel early cardiac markers to give a clear picture of a patient's cardiac status. It can be used in A&E settings as well as cardiac and medical wards to determine the diagnosis of MI, and assess the patient's risk of future cardiac events.

A 3-year study with over 1000 patients confirmed the cardiac biochip to be 89% sensitive for MI diagnosis shortly after a cardiac event (3-6 hours), which constitutes a 20% increase in sensitivity against troponin alone. It also has the ability of ACS profiling and, with a negative predictive value of 98% at 3-6 hours, is a perfect rule-out test for the emergency setting.

All analytes on the cardiac array can be measured simultaneously with a small patient sample using Biochip Array Technology. The Evidence analyser can run 378 cardiac tests per hour, the Evidence Investigator achieves 270 tests in two hours. The Evidence MultiStat is the analyser of choice for fast results within 20 minutes.

http://www.randox.com/cardiac.php 
# 3 of 4
January 25, 2010 10:22 (EST)
Bob Henry
Personally I would go for a Triage for Cardiac testing. It costs about 2k. The Randox technology is being pitched at 70 - 80k. The technology is not even that innovative. SImilar devices were about about 6 years ago.
# 4 of 4
January 25, 2010 10:23 (EST)
Andy Drew
Yeah I think the Triage is the only technology that I would consider for Cardiac testing. Know a guy who works in Randox. They have not sold one of these machines and have had loads of problems in production.

You must be a member (with full membership) to post a comment.
Already a member?
Enter your login information below:
 Remember me on this computer
Forgot your username and/or password?
        Login        
Enjoy all the benefits of theheart.org

With full membership, you can check out our educational and editorial content, search the site, receive our newsletters, join discussions, download slides and much more.

Membership is free!

    Join now for full access    
About The Fellows' Corner
The Fellows' corner on theheart.org radio offers fellow conducted interviews of thought leaders on a wide range of topics such as training, research, career planning, and the daily dilemmas encountered by the cardiovascular physician. Available for download on theheart.org and through iTunes, our podcasts are anecdotal learning tools and words of wisdom from some of our most valued cardiovascular professionals.

If you are a cardiovascular fellow and would like to participate in our series, contact us at info@theheart.org